TAL Daiichi Offers A$11.80 a Share for the Rest of Challenger, Valuing the Retirement-Income Group at A$7.94 Billion

Challenger Limited told shareholders on Monday that its largest shareholder wants the rest of the company — at a set price, on conditions, and with no promise that a binding deal follows.

Challenger Limited (ASX: CGF) announced on Monday, October 19, 2026 that it has received a non-binding and conditional indicative offer from TAL Daiichi Life Australia Pty Limited (TDA), a subsidiary of Daiichi Life Group, Inc., to acquire the remaining 79.5% of ordinary shares in Challenger it does not already own, increasing its ownership to 100%, by way of a scheme of arrangement at a price of A$11.80 per share. The proposal was received after market close on Friday, October 16, 2026. Reuters calculated that the price values Challenger at A$7.94 billion (about $5.53 billion). All Challenger figures in this article are Australian dollars unless stated otherwise.

A premium, measured two ways — and a board that has not said yes

Challenger put the premium at 17.7% to its one-month volume weighted average price (VWAP) of A$10.03 a share; measured against Friday's last close, Reuters put the premium at 19.8%. Neither number is a recommendation. The proposal is subject to a number of conditions including satisfactory completion of due diligence, entry into a scheme implementation agreement on acceptable terms and approval from various regulatory bodies, and Board recommendation. The Board of Challenger is considering the indicative offer. Challenger shareholders do not need to take any action in response to the indicative offer and there is no certainty the proposal will result in a binding offer or that any transaction will eventuate. Challenger said it will continue to keep the market informed in accordance with its continuous disclosure obligations — which makes the board's response, and whether TAL Daiichi is given due diligence, the next two facts that matter.

The bidder already sits inside the register

This is an insider's bid, not a stranger's raid. TAL Daiichi first bought into Challenger in April 2025, when Daiichi Life announced that TAL had agreed to acquire a shareholding of 15.1% of issued shares (104,353,125 shares) in Challenger for ¥80 billion from MS&AD Insurance Group Holdings, Inc., subject to regulatory approvals. The holding has since grown to the stake implied by Monday's release — TDA does not already own 79.5% of the company, and the scheme would lift it to 100%. A bidder that already owns about a fifth of the target, knows the book and has sat through a full results cycle starts due diligence with an information advantage an outside buyer would not have, which is precisely why the board's handling of access and price will be scrutinised by the other four-fifths of the register.

The offer lands on a growth quarter

Challenger published its first-quarter update in the same Monday release window, and it reads like a business accelerating into the bid rather than limping toward it. Total sales increased 52% to A$4.4 billion, driven by record annuity sales: annuity sales increased by 72% to A$2.8 billion, fixed term sales were up 103% to A$2.2 billion, and offshore reinsurance sales rose 30% to A$320 million on strong demand for Yen-denominated annuities in Japan. Net annuity flows were A$1.1 billion, with annuity book growth of 6.3% for the quarter, and Challenger's assets under management rose 5% for the quarter to A$31.9 billion. Managing Director and Chief Executive Officer Nick Hamilton said the company had started the year strongly, with continued momentum across its retirement business. The quarter also brought the inaugural A$750 million three-year note under the A$6 billion Challenger Annuity-Backed Notes program launched in July.

What the board is weighing against A$11.80

The full-year baseline is the year ended June 30, 2026: normalised net profit after tax of A$468 million, up 3%, statutory net profit of A$506 million, annuity sales up 19% to A$6.2 billion, a full-year ordinary dividend of 31.5 cents per share plus a 1.5 cent special dividend, and an upsized share buy-back to A$450 million. In other words, the board is being asked to sell a company that was, until Monday, returning capital to shareholders and guiding to growth — at a premium of under a fifth to its average recent price. Challenger is also mid-restructure: the proposed merger of its Fidante funds business with Channel Capital remains on track for completion later this half, after which Challenger will own 45% of the merged entity, and Fidante's funds under management were A$85 billion in the first quarter. Whether TAL Daiichi's price pays for that growth path — the annuity book compounding at 6.3% in a single quarter — is the argument the board now has to have in public. The first market verdict arrives with Monday's ASX session, the first trading since the proposal landed after Friday's close.